1. Diab A, Tannir NM, Bentebibel SE, Hwu P, Papadimitrakopoulou V, Haymaker C, Kluger HM, Gettinger SN, Sznol M, Tykodi SS, Curti BD, Tagliaferri MA, Zalevsky J, Hannah AL, Hoch U, Aung S, Fanton C, Rizwan A, Iacucci E, Liao Y, Bernatchez C, Hurwitz ME, Cho DC (2020) Bempegaldesleukin (NKTR-214) plus Nivolumab in patients with advanced solid tumors: phase I dose-escalation study of safety, efficacy, and immune activation (PIVOT-02). Cancer Discov 10(8):1158–1173
2. Ailincai D, Dorobanțu AM, Dima B, Irimiciuc ȘA, Lupașcu C, Agop M, Olguta O (2020) Poly(vinyl alcohol boric acid)-diclofenac sodium salt drug delivery systems: experimental and theoretical studies. J Immunol Res 2020:1–14
3. Agop M, Merches I (2019) Operational procedures describing physical systems. Taylor & Francis Group, Boca Raton, FL
4. Agop M, Paun VP (2017) On the new perspectives of fractal theory. Fundaments and applications. Romanian Academy Publishing House, Bucharest
5. Ai L, Xu A, Xu J (2020) Roles of PD-1/PD-L1 pathway. Signalling, cancer and beyond in regulation of cancer immune checkpoints. Molecular and cellular mechanisms and therapy. Springer, Singapore, pp 63–81